ARF directly binds DP1: Interaction with DP1 coincides with the G 1 arrest function of ARF

Molecular and Cellular Biology

Volumn 25, Issue 18, 2005, Pages 8024-8036

  Datta, Abhishek ^a   Sen, Jayita ^a   Hagen, Jussara ^b   Korgaonkar, Chandrashekhar K ^b,c   Caffrey, Michael ^a   Quelle, Dawn E ^b   Hughes, Douglas E ^a   Ackerson, Timothy J ^a   Costa, Robert H ^a   Raychaudhuri, Pradip ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; DNA BINDING PROTEIN; DP1 PROTEIN; MUTANT PROTEIN; PROTEIN; PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; CULTURE SHOCK; DHFR GENE; GENE; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENIC STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SHOCK; STRESS;

ANIMALS; CELL CYCLE PROTEINS; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; MICE; MUTATION; PROMOTER REGIONS (GENETICS); TETRAHYDROFOLATE DEHYDROGENASE; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 24344433172     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.18.8024-8036.2005     Document Type: Article

References (71)

1. Aslanian, A., P. J. Iaquinta, R. Verona, and J. A. Lees. 2004. Repression of the ARF tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev. 18:1413-1422.
2. Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Jonhson, and N. B. LaThangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle regulating transcription factor E2F/DRTF. EMBO J. 12:4317-4324.
3. Bargou, R. C., C. Wagener, K. Bommert, W. Arnold, P. T. Daniel, M. Y. Mapara, E. Grinstein, H. D. Royer, and B. Dorken. 1996. Blocking of transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J. Exp. Med. 183:1205-1213.
4. Bates, S., A. C. Phillips, P. A. Clark, F. Stott, G. Peters, R. L. Ludwig, and K. H. Vousden. 1998. p14ARF links the tumor suppressors Rb and p53. Nature 395:124-125.
5. Berwistle, D., M. Sugimoto, and C. J. Sherr. 2004. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol. Cell. Biol. 24:985-996.
6. Campanero, M. R., and E. K. Flemington. 1997. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:2221-2226.
7. Carnero, A., J. D. Hudson, C. M. Price, and D. H. Beach. 2000. p16INK4a and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol. 2:148-155.
8. Datta, A., A. Nag, and P. Raychaudhuri. 2002. Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF. Mol. Cell. Biol. 22:8398-8408.
9. Datta, A., A. Nag, W. Pan, N. Hay, A. L. Gartel, O. Colamonici, Y. Mori, and P. Raychaudhuri. 2004. Myc-ARF (alternate reading frame) interactions inhibit the functions of Myc. J. Biol. Chem. 279:36698-36707.
10. ARF tumor suppressor. Genes Dev. 12:2434-2442.
11. Dimri, G. P., K. Itahana, M. Acosta, and J. Campisi. 2000. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor. Mol. Cell. Biol. 20:273-285.
12. Dyson, N. 1998. The regulation of E2F by pRb-family members. Genes Dev. 94:2245-2262.
13. Eymin, B., L. Karayan, P. Seite, C. Brambilla, E. Brambilla, C. Larsen, and S. Gazzeri. 2001. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 20:1033-1041.
14. Girling, R., J. F. Patridge, L. R. Bandara, N. Burden, N. F. Totty, J. J. Hsuan, and N. B. LaThangue. 1993. A new component of the transcription factor DRTF1/E2F. Nature 362:83-87.
15. Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem. 275:27473-27480.
16. Hateboer, G., R. M. Kerkhoven, A. Shvarts, R. Bernards, and R. L. Beijersbergen. 1996. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10:2960-2970.
17. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
18. Helin, K., C.-L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factor E2F1 and DP1 leads to cooperative transactivation. Genes Dev. 7:1850-1861.
19. Hofmann, F., F. Martelli, D. M. Livingston, and Z. Wang. 1996. The retinoblastoma gene product protects E2F1 from degradation by the ubiquitin-proteasome pathway. Genes Dev. 10:2949-2959.
20. Honda, R., and H. Yasuda. 1999. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18:22-27.
21. Itahana, K., K. P. Bhat, K. P. Jin, Y. Itahana, D. Hawke, R. Kobayashi, and Y. Zhang. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 12:1151-1164.
22. Jooss, K., E. W. F. Lam, A. Bybee, R. Girling, R. Muller, and N. B. La Thangue. 1995. Proto-oncogenic properties of the DP family of proteins. Oncogene 10:1529-1536.
23. Kalinichenko, V., M. L. Major, X. Wang, J. Kuechle, H. M. Yoder, M. B. Dennewitz, B. Shin, A. Datta, P. Raychaudhuri, and R. H. Costa. 2004. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 18:830-850.
24. ARF. Cell 91:649-659.
25. Kamijo, T., J. D. Weber, G. Zambetti, F. Zindy, M. F. Roussel, and C. J. Sherr. 1998. Functional and physical interaction of the ARF tumor suppressor with p53 and MDM2. Proc. Natl. Acad. Sci. USA 95:8292-8297.
26. Kohn, M. J., R. T. Bronson, E. Harlow, N. J. Dyson, and L. Yamasaki. 2003. DP1 is required for extra-embryonic development. Development 130:1295-1305.
27. Korgaonkar, C., L. Zhao, M. Modestou, and D. E. Quelle. 2002. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol. Cell. Biol. 22:196-206.
28. Krek, W., G. Xu, and D. M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase check-point. Cell 83:1149-1158.
29. Kubbutat, M. H. G., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
30. Kuo, M., E. J. Duncavage, R. Mathew, W. Besten, D. Pei, D. Naeve, T. Yamamoto, C. Cheng, C. J. Sherr, and M. F. Roussel. 2003. Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res. 63:1046-1053.
31. Reference deleted.
32. Llanos, S., P. A. Clark, J. Rowe, and G. Peters. 2001. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat. Cell Biol. 3:445-452.
33. Lohrum, M. A., M. Ashcroft, M. H. G. Kubbutat, and K. H. Vousden. 2000. Contribution of two independent MDM2-binding domains in p14ARAF to p53 stabilization. Curr. Biol. 10:539-542.
34. Loughran, O., and N. B. La Thangue. 2000. Apoptotic and growth-promoting activity of E2F modulated by MDM2. Mol. Cell. Biol. 20:2186-2197.
35. Maehara, K., K. Yamakoshi, N. Ohtani, Y. Kubo, A. Takahashi, S. Arase, N. Jones, and E. Hara. 2005. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional Rb and p53. J. Cell Biol. 168:553-560.
36. Reference deleted.
37. Martelli, F., T. Hamilton, D. P. Silver, N. E. Sharpless, N. Bardeesy, M. Rokas, R. A. DePinho, D. M. Livingston, and S. R. Grossman. 2001. p19ARF targets certain E2F species for degradation. Proc. Natl. Acad. Sci. USA 98:4455-4460.
38. Marti, A., C. Wirbelauer, M. Scheffner, and W. Krek. 1999. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1:14-19.
39. Reference deleted.
40. Mason, S. L., O. Loughran, and N. B. La Thangue. 2002. p14(ARF) regulates E2F activity. Oncogene 21:4220-4230.
41. Midgley, C. A., J. M. Desterro, M. K. Saville, S. Howard, A. Sparks, R. T. Hay, and D. P. Lane. 2000. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19:2312-2323.
42. Morosov, A., W. C. Phelps, and P. Raychaudhuri. 1994. Activation of the c-fos gene by the HPV-16 oncoproteins depends upon the cAMP-response element at -60. J. Biol. Chem. 269:18434-18440.
43. Ohta, T., and Y. Xiong. 2001. Phosphorylation- and SKP1-independent in vitro ubiquitination of E2F1 by multiple ROC-Cullin ligases. Cancer Res. 61:1347-1353.
44. Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumor-suppressor p53. Nature 362:857-860.
45. Ossovskaya, V. S., I. A. Mazo, M. V. Chernov, O. B. Chernova, Z. Strezoska, R. Kondratov, G. R. Stark, P. M. Chumakov, and A. V. Gudkov. 1996. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. Proc. Natl. Acad. Sci. USA 93:10309-10314.
46. Palmero, I., C. Pantoja, and M. Serrano. 1998. p19ARF links the tumor suppressor p53 to Ras. Nature 395:125-126.
47. Pomerantz, J., N. Schreiber-Agus, N. J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, and R. A. DePinho. 1998. The Ink4a tumor-suppressor gene product, p19ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713-734.
48. Qi, Y., M. A. Gregory, Z. Li, J. P. Brousal, K. West, and S. R. Hann. 2004. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431:712-717.
49. Quelle, D. E., F. Zindy, R. A. Ashmun, and C. J. Sherr. 1995. Alternative reading frames of the Ink4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
50. Radfar, A., I. Unnikrishnan, H.-W. Lee, R. A. DePinho, and N. Rosenberg. 1998. p19ARF induces p53 dependent apoptosis during Abelson virus-mediated B-cell transformation. Proc. Natl. Acad. Sci. USA 95:13194-13199.
51. Rowland, B. D., S. G. Denissov, S. Douma, H. G. Stunnenberg, R. Bernards, and D. S. Pepper. 2002. E2F transcriptional repressor complexes are critical downstream targets of p19ARF/p53-induced proliferative arrest. Cancer Cell 2:55-65.
52. Sage, J., A. L. Miller, P. A. Perez-Mancera, J. M. Wysocki, and T. Jacks. 2003. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424:223-228.
53. Serrano, M., A. W. Lin, M. E. Mccurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic Ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
54. Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991.
55. Sherr, C. J. 2001. The INK4a/ARF network in tumor suppression. Nat. Rev. 2:731-737.
56. Stevens, C., and N. B. La Thangue. 2003. E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 412:157-169.
57. Stott, F. J., S. Bates, M. C. James, B. B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K. H. Vousden, and G. Peters. 1998. The alternative product from the human CDK2NA locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:5001-5014.
58. Sugimoto, M., M. Kuo, M. F. Roussel, and C. J. Sherr. 2003. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell 11:415-424.
59. Tao, W., and A. J. Levine. 1999. p19ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA 96:6937-6941.
60. Wang, D., J. Russell, H. Xu, and D. J. Johnson. 2001. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis. Mol. Carcinog. 31:90-100.
61. Weber, J. D., L. J. Taylor, M. F. Roussel, C. J. Sherr, and D. Bar-Sagi. 2000. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20-26.
62. Weber, J. D., J. R. Jeffers, J. E. Rehg, D. H. Randle, G. Lozano, M. F. Roussel, C. J. Sherr, and G. P. Zambetti. 2000. p53-independent functions of the p19ARF tumor suppressor. Genes Dev. 14:2358-2365.
63. Weber, J. D., M.-L. Kuo, B. Bothner, E. L. DiGiammarino, R. W. Kriwacki, M. F. Roussel, and C. J. Sherr. 2000. Cooperative signals governing ARF-Mdm2 interaction and nucleolar relocalization of the complex. Mol. Cell. Biol. 20:2517-2528.
64. Wu, C. L., L. R. Zukerberg, C. Ngwu, E. Harlow, and J. A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15:2536-2546.
65. Wu, L., C. Timmers, B. Maiti, H. I. Saavedra, L. Song, G. T. Chong, F. Nuckolls, P. Giangrande, F. A. Wright, S. J. Field, M. E. Greenberg, S. Orkin, J. R. Nevins, M. L. Robinson, and G. Leone. 2001. The E2F1-3 transcription factors are essential for cell proliferation. Nature 414:457-462.
66. Ink4a, TGFβ, and contact inhibition. Cell 97:53-61.
67. Zhang, Y., Y. Xiong, and W. G. Yarbrough. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734.
68. Zhang, Y., and Y. Xiong. 1999. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3:579-591.
69. Zhang, Y., and Y. Xiong. 2001. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 12:175-186.
70. Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424-2433.
71. Zindy, F., R. T. Williams, T. A. Baudino, J. E. Rehg, S. X. Skapek, J. L. Cleveland, M. F. Roussel, and C. J. Sherr. 2003. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc. Natl. Acad. Sci. USA 100:15930-15935.